ICAM1 and cancer: Accordingly, cannabinoids, a group of substances with diverse anticarcinogenic properties, have been shown to enhance the susceptibility of lung cancer cells to cytolytic death mediated by lymphokine-activated killer (LAK) cells via increase of ICAM-1 on cancer cell surface [26].